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Percutaneous coronary laser thermal angioplasty was
successfully performed before conventional balloon an-
gioplasty in it 55 year old white man with a 90% left
anterior descending artery stenotic lesion and angina at
rest (Canadian Heart Association class IV). The lesion
was reduced to 50% residual stenosis using a 1.7 mm
laser-heated metallic capped fiber and two pulses of 8
W of argon laser energy, each delivered for 5 seconds.
With subsequent balloon angioplasty, the lesion was fur-
ther decreased to 10% residual stenosis. The entire pro-
cedure was well tolerated without chest pain or burning,
The use of laser energy transmitted through flexible fiber-
optic fibers has the potential to serve as an adjunct or al-
ternative to conventional balloon angioplasty because it re-
moves obstructing atheroma or thrombus by vaporization
rather than by merely stretching or fracturing the plaque as
balloon angioplasty does (I). However, to date the technique
of laser recanalization or laser angioplasty has been limited
by inadequate delivery systems that result in an unacceptably
high perforation rate in experimental (2,3) and clinical stud-
ies (4,5). In addition, direct laser angioplasty creates small
recanalized channels that result in poor long-term patency
(4). Recently, a novel fiberoptic laser delivery system has
been developed (Trimedyne, Inc.) in which argon laser en-
ergy is converted to heat in a rounded metallic cap at the
end of a fiber (6) (Fig. I). Experimental studies in athero-
sclerotic rabbits (2) indicate that less vessel perforation and
greater resolution of angiographic stenoses were possible
with this laser-heated probe than with bare fibers.
With this background in experimental animals, a clinical
trial was conducted with the laser-heated probe in which
percutaneous laser recanalization was possible in 50 (89%)
of 56 femoropopliteal occlusions (7). Thus, laser thermal
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vesselperforation or spasm, thrombus formation or em-
bolization of debris. The patient was free of pain at 1
month follow-up.
This case demonstrates the feasibility of safely per-
forming percutaneous coronary laser thermal angio-
plasty. Additional studies are indicated to determine the
clinical role and potential benefitsof coronary laser ther-
mal angioplasty in relation to the established procedures
of bypass surgery and conventional balloon angioplasty.
(1 Am Coil Cardiol 1986;8:1437-40)
angioplasty as an adjunct to balloon angioplasty was found
safe and effective in human peripheral vessels and there was
a suggestion that the technique may increase the proportion
of patients suitable for angioplasty. Based on this experi-
ence, a trial of percutaneous coronary laser thermal angio-
plasty as an adjunct to balloon angioplasty was begun using
a specially designed 1.7 mm coronary laser-heated probe
developed in a canine model (Sanborn TA, et al., unpub-
lished results). This brief report describes our first experi-
ence with percutaneous coronary laser thermal angioplasty.
Case Report
A 55 year old white man was referred for angioplasty of
a 90% eccentric left anterior descending artery lesion be-
cause of a 6 month history of angina on effort progressing
in severity to angina at rest (Canadian Heart Association
class IV) despite treatment with nadolol (40 mg/day), ni-
troglycerin patch (10 mg/day), nifedipine (20 mg three
times/day), aspirin (325 mg three times/day) and dipyrid-
amole (75 mg three times/day). On June 27, 1986, after
informed consent was obtained under a protocol approved
by the Institutional Review Board at University Hospital,
Boston University Medical Center and the United States
Food and Drug Administration, the patient was prepared for
laser thermal angioplasty using standard angioplasty tech-
niques by way of the percutaneous femoral approach. After
heparin bolus (10,000 U given intravenously) and intracor-
onary nitroglycerin administration (200 p,g), biplane right
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Figure 1. A 1.7 rnrnlaser-he ated metallic capped fiber
positioned over a 0 .0 12 inch (0 .03 em) guide wire . A
channel at the distal end of the laser probe allows it to
be advanced over the guide wire.
and left coronary arteriography confirmed a 90% eccentric
atherosclerotic or thrombotic left anterior descending artery
lesion located just after the first septal perforator.
Laser thermal angioplasty procedure. With an 8F large
lumen guiding catheter (USCl) in place in the ostium of the
left main coronary artery , a 1.7 mm coro nary laser-heated
probe (Trimedyne, Inc.) on a 300 J.L diameter quart z core
fiber was adva nced through the guiding catheter over a 0.0 12
inch (0. 03 em) diameter, 118 inch (300 em) long Kaltenbach
guide wire (Schneider Medntag). First , under fluoroscopic
guidance the guide wire was advanced separately through
the lesion into the distal left anterior descending artery with
its location confirmed angiographically as in the standard
angioplasty technique . Second , the 1.7 mm coronary laser
probe was adva nced over the guide wire through the left
main coronary artery and proximal left anterior descending
artery up to the lesion . With gentle pressure , mechanical
advancement of the laser probe through the lesion without
laser power was attempted but was unsuccessful. Next. ad-
vancement of the laser probe was attempted using a 5 second
pulse of 8 W of continuous argon laser energy delivered
through the fiber from a 14 W argon laser (Optilase , model
900, Trimedyne, Inc.). During advancement of the laser
probe, a continuous motion was applied to the device, par-
ticularl y during the cooling period (2 to 5 seconds), to pre-
vent adherence of the device to the vessel wall.
Laser thermal angioplasty results. Laser recanaliza-
tion of the 90% left anterior descending artery lesion was
successfully performed with the 1.7 mm laser probe using
two pulses, each lasting 5 seconds . During the first laser
pulse del ivery, recanal ization was not complete, in part
because the guiding catheter buckled out of the left main
coronary artery. With a better guiding catheter position, the
second laser pulse to the laser probe successfully recanalized
the lesion. The patient did not experience any chest pain ,
burnin g sensation or arrhythmia during the laser pulse de-
livery. Repeat coronary angiography demonstrated a resid-
ual 50% lesion without evidence of luminal irregularities,
dye extravasation, spasm, thrombus formation or emboli-
zation of debris.
Balloon angioplasty procedure. To ensure an adequate
lumen after laser therm al angioplasty, conventional balloon
angioplasty was performed . Leaving the guide wire in place
distal to the lesion , the laser probe was withdrawn from the
Figure 2. The 60° left anterior oblique, J00 caudal views of the
90% eccentric left anterior descending artery lesion (a r rows) be-
fore treatment (top). after laser thermal angioplasty with the laser
probe through the lesion and the angiographic result of laser ther-
mal angioplasty (middle panels) and after balloon angioplasty
(bottom) .
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guiding catheter, a 3.0 mm LPS balloon dilation catheter
(USCI) was exchanged over the guide wire and conventional
balloon angioplasty was performed. During the laser probe
and balloon catheter exchange over the guide wire, there
was no significant change in the percent stenosis as docu-
mented by repeat angiography just before balloon advance-
ment through the lesion. After the enlargement of the arterial
lumen with the laser probe, the residual lesion was crossed
very easily with the 3.0 mm LPS balloon catheter. After
two balloon inflations to 4 and 6 atm of pressure for 20 and
30 seconds, respectively, repeat angiography revealed a
smooth contoured vessel without any luminal irregularities
and a 10% residual stenosis. Angiographic examples of the
lesion before treatment, after laser recanalization and after
balloon dilation are shown in Figure 2. The patient tolerated
the entire procedure very well and was discharged home
within 48 hours. Four weeks after the procedure, he remains
asymptomatic.
Discussion
Percutaneous coronary laser thermal angioplasty. This
patient represents the first case report of a successful per-
cutaneous coronary laser thermal angioplasty procedure. The
1.7 mm coronary laser-heated probe proved effective in
partially reducing the 90% left anterior descending artery
lesion to 50% residual stenosis without any complications
such as chest pain, burning, arrhythmia, vessel perforation,
spasm, thrombosis, dissection or embolization. A left an-
terior descending artery lesion was chosen for this first case
to evaluate the potential of this technique in a vessel with
minimal tortuosity and provide the least risk to the patient
(8,9).
Study intent and implications. These results are quite
encouraging in that they demonstrate the feasibility of per-
forming percutaneous coronary laser thermal angioplasty
safely in a nonoperative setting to remove a coronary ath-
erosclerotic or thrombotic obstruction using standard cardiac
catheterization techniques. Prior clinical studies of coronary
laser angioplasty have been performed intraoperatively dur-
ing coronary artery bypass surgery (4,10). The intent of this
study was only to document the safety of this procedure,
not its effectiveness in assisting balloon angioplasty. How-
ever, taken together with a prior study in peripheral vessels
(7), this technique of percutaneous laser thermal angioplasty
does have considerable potential in expanding the anatomic
subsets in which angioplasty is feasible. Conceivably, it
may also diminish the incidence of restenosis. Further de-
vice modifications will be required, however, to approach
the more tortuous coronary vessels and to achieve a more
complete result. An important goal in future studies will be
to determine the clinical utility of this new technology in
the treatment of coronary artery disease in relation to ex-
isting treatment modalities such as bypass surgery and con-
ventional balloon angioplasty.
The role of Hany Hussein. PhD and Stanislaw Sulek of Trimedyne, Inc.
in the development and design of the coronary laser probe is greatly ap-
preciated. The authors are indebted to K.R. Shankar. MD and E.E. Drago,
MD for their referral of this patient.
Addendum
Since this initial case was performed, percutaneous coro-
nary laser thermal angioplasty has been attempted on a total
of seven patients at Boston University Medical Center. Laser
recanalization proved successful in four patients, but failed
in three instances in which vessel tortuousity and device
profile prevented complete recanalization of the lesion. In
two of these laser angioplasty failures, a successful result
was obtained with more flexible, lower profile balloon cath-
eters. In one patient, neither laser recanalization nor balloon
angioplasty was successful, and the patient underwent a
successful bypass operation. We encountered no perfora-
tions, dissections, distal emboli or myocardial infarctions
as a result of the laser procedure.
Two brief reports of coronary laser thermal angioplasty
have already appeared since this case was performed on
June 27, 1986 (11,12). Cumberland et al. (II) used a pro-
tocol similar to ours but encountered complications of myo-
cardial infarction or myocardial enzyme elevation in three
of four patients. Another group working intraoperatively
perforated one of three coronary arteries using a probe de-
signed for peripheral laser angioplasty which was not equipped
for passage over a guide wire (12).
While these studies demonstrate that coronary laser ther-
mal angioplasty is feasible, it seems clear that considerable
technologic advancements in catheter design are required to
improve the safety and efficacy of this new technique.
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